1. Introduction {#sec1-molecules-25-02151}
===============

The search for new, safer, and sustainable high-added-value compounds relies to a certain degree on the continuous study of traditionally used medicinal plants \[[@B1-molecules-25-02151]\]. These plants have been used since ancient times for their countless benefits, being associated with health-promoting properties \[[@B2-molecules-25-02151],[@B3-molecules-25-02151]\]. Conventionally prepared as an infusion, decoction, or by maceration (also used for culinary purposes due to their fragrance and flavor), these herbs can be blended in different combinations of leaves, roots, barks, stems, and flowers, among other plant materials \[[@B4-molecules-25-02151]\]. One of the botanical families containing an enormous range of species most commonly consumed as herbal tea is the Lamiaceae family, which brings together an enormous range of plants (e.g., *Rosmarinus officinalis* L. and *Thymus mastichina* L.) that have several recognized bioactive properties and beneficial health effects \[[@B5-molecules-25-02151],[@B6-molecules-25-02151],[@B7-molecules-25-02151]\]. Another widely used botanical family is the Asteraceae family, comprising plants such as *Calendula arvensis* L. and *Chamaemelum nobile* L., which have been extensively studied \[[@B8-molecules-25-02151],[@B9-molecules-25-02151],[@B10-molecules-25-02151]\] and also present a wide range of bioactive properties. The species I this family are of great commercial and economic value, with potential to be applied in the food and pharmaceutical industries. There are other plant families that are still underexplored, despite showing promising potential to be used as sources of high-added-value compounds, such as Lauraceae (e.g., *Laurus nobilis* L.), Oleaceae (e.g., *Olea europaea* L.), Vitaceae (e.g., *Vitis vinifera* L.), Apiaceae (e.g., *Foeniculum vulgare* Mill.), and Juglandaceae (e.g., *Juglans regia* L.) families, among others \[[@B11-molecules-25-02151],[@B12-molecules-25-02151],[@B13-molecules-25-02151],[@B14-molecules-25-02151],[@B15-molecules-25-02151]\]. The demand of today's consumers for foods marketed as healthier and natural has led the food industry to seek new formulation products to meet their high expectations \[[@B16-molecules-25-02151]\], such as blending herbs from different botanical families. These mixtures can present additive and synergistic effects and increase the content of compounds of interest, improving the nutritional value of these products, and also by acting as sources of functional ingredients to be incorporated into food products \[[@B16-molecules-25-02151],[@B17-molecules-25-02151]\]. In this sense, the present work was performed to chemically characterize six herbal blends (complete description in [Table 1](#molecules-25-02151-t001){ref-type="table"}), namely relating to their profiles in individual sugars and phenolic compounds. Moreover, it also aimed to evaluate their antioxidant, cytotoxic, anti-inflammatory, and antimicrobial properties, comparing these results with previously reported data on the individual plants, allowing a better understanding of the eventual synergistic effects existing in these innovative mixtures.

2. Results and Discussion {#sec2-molecules-25-02151}
=========================

2.1. Nutritional Analysis and Sugar Composition {#sec2dot1-molecules-25-02151}
-----------------------------------------------

The total contents of fat, ash, and proteins in the infused blend were, as expected (and confirmed in previous studies by Caleja et al. \[[@B18-molecules-25-02151]\]), below the limits of detection, and consequently below the limits of quantification of the equipment and protocols used to perform these analyses. Therefore, assuming total sugars as total carbohydrates, the calculation of energy was performed according to the following equation: energy (cal) = 4 × (mg carbohydrates). Data on the free sugar content and energy contribution of the six infusions are shown in [Table 2](#molecules-25-02151-t002){ref-type="table"}.

The qualitative and quantitative profiles of individual sugars in the six blends were quite different, with mix 1, mix 2, and mix 4 presenting fructose and glucose, and mix 3 and mix 6 only revealing the presence of fructose and sucrose, respectively. On the other hand, mix 5 was the only blend presenting these three sugars, also showing the highest concentration of total sugars (75 ± 2 mg/100 mL). Given the fact that this was the only blend containing *O. vulgare* and that it was its main constituent (60%), its high sugar content can be possibly ascribed to this species. In a previous study performed by Pereira et al. \[[@B19-molecules-25-02151]\], a sample of *O. vulgare*, in which the subspecies was not identified, revealed a total sugar content of 19 ± 1 g/100 g of dry plant, also revealing the presence of trehalose; however, in refenced study the infusion was not assessed, so the results are not comparable to the ones presented herein. In mix 1, the most abundant species was *R. officinalis* (50%). For this herbal infusion, no sugars were detected in a previous study \[[@B19-molecules-25-02151]\], which suggests that the sugar content of the mixture is due to the contributions of the other plants (*C. nobile*, *L. nobilis*, and *J. regia*). Indeed, Pereira et al. \[[@B19-molecules-25-02151]\] reported a total sugar content of 15.0 ± 0.2 mg/100 mL for the *C. nobile* infusion and 10.46 ± 0.02 g/100 g of dried sample (not directly comparable) for *L. nobilis*. Regarding mix 2, in a previous study, *F. vulgare* infusion had a total sugar amount of 15.0 ± 0.9 mg/100 mL \[[@B19-molecules-25-02151]\], lower than the one found for this mixture, which was composed of 40% of this plant. This suggests that the remaining plants in the blend had a higher contribution. Given the fact that *S. nigra* and *H. perforatum* were not present in the other herbal blends, this possibility was not discussed further.

Consequently, mix 5 also presented the highest energetic contribution (298 ± 6 cal/100 mL), followed by mix 1 (139 ± 4 cal/100 mL) and mix 2 (122 ± 5 cal/100 mL). As far as we know, there are no reports on these plants' infusion energy values, except for *C. nobile*, *F. vulgare*, *M. pulegium*, *R. officinalis*, and *T. mastichina* individually (59.8 ± 0.9, 60 ± 3, 47.4 ± 0.85, \~0, and 34 ± 2 cal/100 mL, respectively) \[[@B19-molecules-25-02151]\].

2.2. Phenolic Compounds Characterization {#sec2dot2-molecules-25-02151}
----------------------------------------

The retention time (Rt), wavelengths of maximum absorption in the visible region (λ~max~), mass spectral data, and tentative identification of the phenolic compounds in the six blends are presented in [Table 3](#molecules-25-02151-t003){ref-type="table"}. The quantification results (mg/g extract) of the phenolic compounds present in the six blends are presented in [Table 4](#molecules-25-02151-t004){ref-type="table"}. Fifty-two phenolic compounds were found in the six blends, among which twenty-eight were phenolic acids, twenty-three were flavonoids, and two were unknown compounds. All the plants in these blends were previously studied for their phenolic composition profiles. As such, the identification of all the compounds was performed using the bibliographic references described in the footnotes of [Table 3](#molecules-25-02151-t003){ref-type="table"}. Twenty phenolic compounds were detected in mix 1, with peak 30 representing the main compound (luteolin-3'-*O*-glucuronide, 4.6 ± 0.1 mg/g extract). Additionally, this mixture had a high percentage of *R. officinalis*; its main phenolic compounds were not the ones described for the aqueous form of this plant (infusions and decoction) \[[@B20-molecules-25-02151]\] or for hydroethanolic extracts \[[@B6-molecules-25-02151]\], namely rosmarinic acid and its derivatives. In the case of the mixture, *C. nobile* \[[@B8-molecules-25-02151]\] and *L. nobilis* \[[@B21-molecules-25-02151]\] seemed to have a greater influence on the phenolic composition, with luteolin-*O*-glucuronide being the major peak detected. Tuberonic acid hexoside (peak 7, \[M − H\]^−^ at *m/z* 387) showed fragments at *m*/*z* 207, which corresponds to the aglycone after loss of hexose \[M−H−162\]^−^, and has been previously described in other plants of the Lamiaceae family \[[@B22-molecules-25-02151]\]. Nine compounds were tentatively identified in mix 2. This blend comprised *F. vulgare*, *S. nigra*, and *H. perforatum*, and previous studies on the individual phenolic profiles of these plants revealed quercetin glycosylated derivatives as the main compounds \[[@B14-molecules-25-02151],[@B15-molecules-25-02151],[@B23-molecules-25-02151]\], which is in accordance with the results obtained herein, showing peak 20 (quercetin-3-*O*-rutinoside, \[M − H\]^−^ at *m/z* 609) as the main compound (31.1 ± 1.3 mg/g extract). In mix 3, eight compounds were tentatively identified, with oleuropein (peak 44, \[M − H\]^−^ at *m/z* 539) being the major compound found. This is probably due to the 25% content of *M. pulegium*, since these secoiridoid-type compounds are very common and abundant in the *Oleaceae* family \[[@B12-molecules-25-02151],[@B24-molecules-25-02151]\]. Thirteen phenolic compounds were tentatively identified in mix 4, with rosmarinic acid being the major compound (13.03 ± 0.05 mg/g extract). Taking into account the high amount of *M. cervina* in the mixture, and considering a study describing rosmarinic acid as the major compound found in this plant \[[@B25-molecules-25-02151]\], it is possible to state that *M. cervina* has a great influence on the phenolic composition of this blend. Regarding mix 5, twelve phenolic compounds were tentatively identified, and as in the previous mixture, rosmarinic acid was the major compound (33.9 ± 0.1 mg/g of extract). Likewise, the high percentage (60%) of *O. vulgare* should explain this result, since *Origanum* genus plants are characterized by containing rosmarinic acid and its derivatives as the main compounds \[[@B26-molecules-25-02151]\]. Finally, ten compounds were tentatively identified in mix 6, with peak 31 (\[M − H\]^−^ at *m/z* 447) being tentatively identified as kaempferol-*O*-hexoside, the major compound in this mix (35 ± 1 mg/g extract). This was an expected result, since the presence of this compound was described in the individual assessment of the phenolic composition of *T. mastichina* \[[@B6-molecules-25-02151]\], *L. nobilis* \[[@B21-molecules-25-02151]\], and *J. regia* \[[@B27-molecules-25-02151]\].

Regarding the total compositions of phenolic compounds, it was possible to verify that mix 6, mix 5, and mix 2 presented higher contents of total phenolic compounds (72 ± 1, 69.6 ± 0.2, and 65 ± 2 mg/g extract, respectively). In mix 5, the total phenolic compound quantity is mainly due to the presence of phenolic acids (67.1 ± 0.2 mg/g extract), which represents 96% of the total phenolic composition. In mix 6, the total phenolic compound quantity is mainly due to the total flavonoid content (47.1 ± 0.2 mg/g extract), which represents 65.4% of the total composition.

2.3. Bioactive Properties {#sec2dot3-molecules-25-02151}
-------------------------

The results for antioxidant, anti-inflammatory, and cytotoxic activities are shown in [Table 5](#molecules-25-02151-t005){ref-type="table"}.

For TBARS assays, mix 1 and mix 6 presented the lowest IC~50~ values (4.5 ± 0.2 and 6.9 ± 0.3 µg/mL, respectively), which indicates high antioxidant activity. In fact, mix 1 revealed a higher lipid peroxidation inhibition capacity than the positive control, Trolox (5.8 ± 0.6 µg/mL). This activity could be explained by the presence of *R. officinalis*, reported in the literature as an excellent antioxidant plant, which is even applied in foodstuffs such as cottage cheese to increase shelf life \[[@B6-molecules-25-02151]\]. Regarding the good results found for mix 6, the fact is that this blend presented the highest concentration of phenolic compounds, which are often reported as the main compounds responsible for the bioactive properties of plants. In a previous study, *O. vulgare* infusion presented an IC~50~ value of 22.8 ± 0.5 µg/mL, which was a high concentration when compared to 9 ± 1 µg/mL, the IC~50~ value obtained for mix 5 (with 60% of this plant), thus suggesting synergistic effects among the blended plants \[[@B26-molecules-25-02151]\].

In terms of antihemolytic activity, the blend revealing the best results was mix 5, with an IC~50~ value of 4.0 ± 0.6 µg/mL. In fact, this blend presented the highest concentration of phenolic acids, which could be related to its antioxidant properties. All blends, with the exception of mix 2, revealed lower IC~50~ values than the positive control (85 ± 2 µg/mL). Studies developed by Caleja et al. \[[@B42-molecules-25-02151]\] and Ribeiro et al. \[[@B43-molecules-25-02151]\] proved the high antioxidant and antimicrobial potential of *F. vulgare* (present in mix 2) and *R. officinalis* (present in mix 1) and their capacity to increase the shelf life of functionalized foods. Moreover, in a previous study, *S. nigra* (present in mix 2) also revealed antioxidant properties (DPPH and FRAP assays) \[[@B44-molecules-25-02151]\]. It is also reported in the literature that the combination of several plants in a drink beverage can provide a synergistic effect in terms of bioactivities, as their combination improves the antioxidant status and reduces oxidative stress \[[@B45-molecules-25-02151]\].

Regarding cytotoxic activity, except for mix2 and mix 4, all blends revealed the capacity to inhibit the growth of the studied tumor cell lines in concentrations ranging from 175 ± 18 (mix 6 in HepG2) to 320 ± 12 (mix 3 in NCI-H460) µg/mL. Another positive aspects is that none of the mixtures revealed toxicity for non-tumor cells up to 400 µg/mL.

Similar observations could be made for anti-inflammatory activity, with mix 2 and mix 4 being the only blends not showing activity. Among the remaining infusions, mix 6 revealed the highest activity at a concentration of 262 ± 17 µg/mL. Considering the results reported by Dias et al. \[[@B11-molecules-25-02151]\] and Vieira et al. \[[@B27-molecules-25-02151]\], where *L. nobilis* and *J. regia* presented cytotoxic activity, in the present study it was expected that mix 2 and mix 4, containing these plants, would also present these properties, which was not observed. This was possibly due to the fact that such blends also included other species.

Finally, [Table 6](#molecules-25-02151-t006){ref-type="table"} shows the antimicrobial capacity of the six infused blends. It is possible to confirm the excellent antimicrobial potential of all mixtures against the analyzed microorganisms. *S. aureus* and *P. funiculosum* seemed to be the most sensitive microorganisms tested, with the infusions revealing lower minimal inhibitory concentration (MIC) and minimal bactericidal concentration/minimal fungal concentration (MBC/MFC) values than the positive controls. Among the tested blends, mix 1 revealed the highest antibacterial properties, with inhibitory and bactericidal concentrations ranging between 0.25 and 2 mg/mL. These results are in accordance with the ones obtained for *R. officinalis* (50% of the composition of mix 1) hydroethanolic extracts, which showed promising antimicrobial capacity \[[@B41-molecules-25-02151]\]. On the other hand, mix 6 revealed the greatest antifungal activity, being able to inhibit fungal growth at 0.12 to 0.5 mg/mL and presenting fungicidal capacity in concentrations ranging from 0.25 to 5 mg/mL. This blend was more effective than the positive controls for all the tested fungi, except in terms of killing *A. fumigatus*. These results are in accordance with the ones obtained for *Thymus* sp. (70% of the composition of mix 6), which has been prescribed for the treatment of infectious diseases \[[@B33-molecules-25-02151]\]. The antimicrobial capacity of *Thymus* sp. infusion has often been correlated with the presence of flavonoids and phenolic acids \[[@B6-molecules-25-02151],[@B21-molecules-25-02151],[@B46-molecules-25-02151]\].

3. Materials and Methods {#sec3-molecules-25-02151}
========================

3.1. Samples and Infusions Preparation {#sec3dot1-molecules-25-02151}
--------------------------------------

Each dry plant material used to prepare the blends was provided by Ervital^®^ (company based in Castro Daire, Portugal). The botanical identification of the fifteen samples was confirmed by Professor Doctor Ana Maria Carvalho (Polytechnic Institute of Bragança, Trás-os-Montes, Portugal) and consisted of: (i) flowering aerial parts of *Foeniculum vulgare* Mill., *Hypericum perforatum* L., *Mentha cervina* L., *Mentha pulegium* L., *Origanum vulgare* subs. *virens* Hoffm. and Link, and *Thymus mastichina* L; (ii) flower heads of *Calendula arvensis* L., *Chamaemelum nobile* (L.) All., and *Sambucus nigra* L.; and (iii) leaves of *Juglans regia* L., *Laurus nobilis* L., *Olea europaea* L., *Rosmarinus officinalis* L., *Rubus idaeus* L., and *Vitis vinifera* L. The six herbal mixtures (mix 1 to mix 6) were blended based on their folk uses and sensory characteristics, following the proportions and traditional combinations of such species: Mix 1: 50% *R. officinalis*, 20% *C. nobile*, 15% *L. nobilis*, and 15% *J. regia*.; mix 2: 40% *F. vulgare*, 30% *S. nigra*, and 30% *H. perforatum*; mix 3: 50% *M. pulegium*, 25% *O. europaea*, and 25% *V. vinifera*; mix 4: 60% *M. cervine*, 20% *C. arvensis*, and 20% *R. idaeus*; mix 5: 60% *O. vulgare*, 10% *C. nobile*, 15% *L. nobilis*, and 15% *J. regia*.; mix 6: 70% *T. mastichina*, 15% *L. nobilis*, and 15% *J. regia*. All the samples were reduced to a fine powder and protected from light and humidity until further analysis. Furthermore, the preparation of infusions was based on the protocol previously described by Pereira et al. \[[@B47-molecules-25-02151]\] and following particular extraction conditions for each blend: mix 1: 10 g/L, 95 °C, 5--7 min; mix 2: 10 g/L, 90 °C, 4--6 min; mix 3: 4 g/L, 95 °C, 5--8 min; mix 4: 4 g/L, 90 °C, 4--6 min; mix 5: 10 g/L, 90 °C, 5--7 min; and mix 6: 10 g/L, 90 °C, 5--7 min. All samples were filtered through Whatman \# 4 paper, frozen at −20 °C, and then lyophilized. The extracts were protected from light and humidity until further analysis.

3.2. Nutritional Analysis and Sugar Content {#sec3dot2-molecules-25-02151}
-------------------------------------------

Fat, carbohydrate, ash, and protein contents of the six dry infusion extracts were analyzed following the AOAC \[[@B48-molecules-25-02151]\] procedures. Free sugars were analyzed following the method previously described by Barros et al. \[[@B28-molecules-25-02151]\], using HPLC coupled to a refractive index detector (Knauer, Smartline 1000 and Smartline 2300 systems, respectively) and melezitose as internal standard. The results were expressed in mg/100 mL of infusion. Finally, the energetic value was calculated according the equation: energy (cal) = 4 × (mg proteins + mg carbohydrates) + 9 × (mg lipids).

3.3. Phenolic Compounds Composition {#sec3dot3-molecules-25-02151}
-----------------------------------

The dry infusion extracts were resuspended in water at a concentration of 10 mg/mL. The phenolic profile was determined by liquid chromatography (Dionex Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA) with a diode array detector (280, 330, and 370 nm wavelengths) equipped with an ESI source and working in negative mode (Linear Ion Trap LTQ XL, Thermo Scientific, San Jose, CA, USA) \[[@B49-molecules-25-02151]\]. Chromatographic separation was achieved with a Waters Spherisorb S3 ODS-2C18 (3 m, 4.6 mm × 150 mm, Waters, Mil-ford, MA, USA) column thermostat at 35 °C. The solvents used were: (A) 0.1% formic acid in water, (B) acetonitrile. The established isocratic elution gradient was 15% B (5 min), 15% B to 20% B (5 min), 20--25% B (10 min), 25--35% B (10 min), 35--50% B (10 min), and re-equilibration of the column, using a flow rate of 0.5 mL/min \[[@B49-molecules-25-02151]\]. The phenolic compounds were identified by comparing their retention times, UV, and mass spectra values with those obtained from standard compounds and with the literature. For quantitative analysis, 7-level calibration curves prepared with appropriate standards were used. The results were expressed in mg per g of dry extract (mg/g) as mean ± standard deviation of three independent analyses.

3.4. Evaluation of Bioactive Properties {#sec3dot4-molecules-25-02151}
---------------------------------------

### 3.4.1. Antioxidant Activity {#sec3dot4dot1-molecules-25-02151}

All samples were tested by two in vitro assays. The thiobarbituric acid reactive species (TBARS) assay uses a brain porcine homogenate measured by spectrophotometry at 532 nm \[[@B28-molecules-25-02151]\]. This assay is used to determine the TBARS content in various samples, including those used to detect a sort of protective activity (usually antilipoperoxidant activity) using a fat or membrane model and an oxidant to induce the damage. The oxidative hemolysis inhibition (OxHLIA) assay is used to evaluate the antihemolytic activity of the extracts using sheep erythrocytes, measured by spectrophotometry at 690 nm \[[@B50-molecules-25-02151]\]. Hemolysis was previously induced using 2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH). The results were expressed as EC~50~ values (sample concentration providing 50% of antioxidant activity, shown in µg/mL), and Trolox was used as a positive control for both assays.

### 3.4.2. Anti-inflammatory Activity {#sec3dot4dot2-molecules-25-02151}

The anti-inflammatory activity was assessed following a procedure described by Svobodova et al. \[[@B51-molecules-25-02151]\]. The dried extracts were re-dissolved in water at 8 mg/mL and evaluated in mouse lipopolysaccharide (LPS)-stimulated macrophage-like cell line RAW 264.7. The results were expressed as IC~50~ values (sample concentration providing 50% of anti-inflammatory activity, μg/mL) and dexamethasone (50 μM) was used as a positive control.

### 3.4.3. Cytotoxic Activity in Tumor and Non-Tumor Cells {#sec3dot4dot3-molecules-25-02151}

The cytotoxic potential was evaluated in four different human tumor cell lines (HeLa (cervical carcinoma), HepG2 (hepatocellular carcinoma), MCF-7 (breast adenocarcinoma), and NCI-H460 (non-small-cell lung cancer)) and a primary culture of non-tumor cells (PLP2 (porcine liver)). To monitor the growth of cell cultures, which were sub-cultured and plated in 96-well plates (density of 1.0 × 10^4^ cells/well), a phase-contrast microscope was used, following the protocol defined by Guimarães et al. \[[@B8-molecules-25-02151]\]. Ellipticin was used as a positive control, and the results were expressed as GI~50~ values (sample concentration that inhibited 50% of cell growth, μg/mL).

### 3.4.4. Antimicrobial Activity {#sec3dot4dot4-molecules-25-02151}

The antibacterial activity was evaluated using Gram (+) bacteria (*Bacillus cereus* (food isolate), *Listeria monocytogenes* (NCTC 7973), *Staphylococcus aureus* (ATCC 6538), and *Micrococcus flavus* (ATCC 10240)), as well as Gram (−) bacteria (*Enterobacter cloacae* (human isolate) and *Salmonella* Typhymurium (ATCC 13311)), following a protocol previously described by Soković et al. \[[@B46-molecules-25-02151]\]. On the other hand, *Aspergillus niger* (ATCC 6275), *Aspergillus versicolor* (ATCC 11730), *Aspergillus fumigatus* (ATCC 9197), *Penicillium funiculosum* (ATCC 36839), and *Penicillium aurantiogriseum* (food isolate) were used to evaluate the antifungal activity, following the protocol described by Soković and Van Griensven \[[@B52-molecules-25-02151]\]. Sodium sulphite (E221) and potassium metabisulphite (E224) food additives were used as positive controls for both activities. The microorganisms are deposited at the Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade. The results were expressed as minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC), and minimal fungicidal concentration (MFC) values.

3.5. Statistical Analysis {#sec3dot5-molecules-25-02151}
-------------------------

For each herbal blend, three individual samples were analyzed, and all assays were prepared in triplicate. The results were analyzed using one-way analysis of variance (ANOVA), followed by Tukey's HSD test as *p* = 0.05, and are expressed as mean values with standard deviation (SD). When less than three results were present in each individual analysis, Student's *t*-test *p*-values were used to determine the significant difference, with *p* = 0.05. Both of these statistical treatments were carried out using the SPSS v.22.0 program.

4. Conclusions {#sec4-molecules-25-02151}
==============

The infusions of different blended species proved to be valuable sources of high-added-value compounds and also showed high capacity for bioactive activity. Given the wide variety of species in each sample, a great variability in results was also expected, rather than obtaining a mixture that stood out in terms of all the analyzed parameters. However, mix 5 had higher contents of soluble sugar, energy contribution, total phenolic acids, and a higher capacity to inhibit erythrocyte hemolysis and the proliferation of the HeLa tumor cell line. Mix 6 presented the highest content of total phenolic compounds (especially flavonoids), higher capacity to inhibit the growth of HepG2 tumor cell line, higher anti-inflammatory activity, and higher antifungal activity. Finally, mix 1 revealed a higher capacity to inhibit lipid peroxidation in the TBARS assay, higher capacity to inhibit the growth of the MCF-7 tumor cell line, and higher antibacterial potential, presenting the lowest MIC and MBC values for Gram-positive and Gram-negative bacteria (even lower than the positive controls). The fact that blends 1, 5, and 6 contain 15% *L. nobilis* and 15% *J. regia* in their composition could explain the better results obtained with these plant mixtures compared to the other ones that did not contain any of these species. As stated earlier, *L. nobilis* and *J. regia* have already been described as highly promising plants for obtaining high-added-value compounds with bioactive potential. Future studies will be necessary to evaluate the real synergistic effects presented by these two plants in the presence of others, and to evaluate their potential for further application in various food, pharmaceutical, and nutraceutical products.
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molecules-25-02151-t001_Table 1

###### 

Description and morphological characteristics of the six herbal blends provided by Ervital^®^ company.

  ----------------------------------------- ------------------------------------- -------------------------------------
  **Mix 1**                                 **Mix 2**                             **Mix 3**

  ![](molecules-25-02151-i001.jpg)          ![](molecules-25-02151-i002.jpg)      ![](molecules-25-02151-i003.jpg)

  50% *R. officinalis*, 20% *C. nobile*,\   40% *F. vulgare*, 30% *S. nigra*,\    50% *M. pulegium*,\
  15% *L. nobilis, 1*5% *J. regia*          30% *H. perforatum*                   25% *O. Europea*, 25% *V. vinifera*

  **Mix 4**                                 **Mix 5**                             **Mix 6**

  ![](molecules-25-02151-i004.jpg)          ![](molecules-25-02151-i005.jpg)      ![](molecules-25-02151-i006.jpg)

  60% *M. cervine*, 20% *C. arvensis*\      60% *O. vulgare*, 10% *C. nobile*,\   70% *T. mastichina*,\
  20%, *R. idaeus*                          15% *L. nobilis*, 15% *J. regia*      15% *L. nobilis*, 15% *J. regia*
  ----------------------------------------- ------------------------------------- -------------------------------------

The morphological characteristics of the six herbal blends were flowering aerial parts of *Foeniculum vulgare* Mill., *Hypericum perforatum* L., *Mentha cervina* L., *Mentha pulegium* L., *Origanum vulgare* subs. *virens* Hoffm. and Link, and *Thymus mastichina* L; flower heads of *Calendula arvensis* L., *Chamaemelum nobile* (L.) All., and *Sambucus nigra* L.; and leaves of *Juglans regia* L., *Laurus nobilis* L., *Olea europaea* L., *Rosmarinus officinalis* L., *Rubus idaeus* L., and *Vitis vinifera* L.

molecules-25-02151-t002_Table 2

###### 

Free sugar and carbohydrate contents and energy contributions of the six infused blends (mean ± SD).

                            Mix 1            Mix 2            Mix 3           Mix 4            Mix 5            Mix 6
  ------------------------- ---------------- ---------------- --------------- ---------------- ---------------- ----------------
  Free sugars (mg/100 mL)                                                                                       
  Fructose                  22.1 ± 0.4 ^b^   13.3 ± 0.6 ^c^   9.1 ± 0.4 ^d^   13.3 ± 0.3 ^c^   30 ± 1 ^a^       nd
  Glucose                   12.6 ± 0.5 ^c^   17.1 ± 0.7 ^a^   nd              3.5 ± 0.1 ^d^    15.3 ± 0.5 ^b^   nd
  Sucrose \*                nd               nd               nd              nd               29 ± 1           6.5 ± 0.1
  Total sugars              35 ± 1 ^b^       30 ± 1 ^c^       9.1 ± 0.4 ^e^   16.8 ± 0.1 ^d^   75 ± 2 ^a^       6.5 ± 0.1 ^f^
  Energy (cal/100 mL)       139 ± 4 ^b^      122 ± 5 ^c^      36 ± 1 ^e^      67.2 ± 0.6 ^d^   298 ± 6 ^a^      25.8 ± 0.3 ^f^

Protein, ash, and fat contents were zero; results expressed as medium value ± standard deviation (SD); nd = not detected. Mix 1: 50% *R. officinalis*, 20% *C. nobile*, 15% *L. nobilis*, 15% *J. regia*. Mix 2: 40% *F. vulgare*, 30% *S. nigra*, 30% *H. perforatum*. Mix 3: 50% *M. pulegium*, 25% *O. europaea*, 25% *V. vinifera*. Mix 4: 60% *M. cervine*, 20% *C. arvensis*, 20% *R. idaeus*. Mix 5: 60% *O. vulgare*, 10% *C. nobile*, 15% *L. nobilis*, 15% *J. regia*. Mix 6: 70% *T. mastichina*, 15% *L. nobilis*, 15% *J. regia.* The statistical treatment was performed by comparing the mixtures; therefore, in each row different letters indicate statistically significant differences (*p* \< 0.05). \* For sucrose individually, the statistical analysis was performed using the Student's *t*-test *p*-value, \<0.001.

molecules-25-02151-t003_Table 3

###### 

Retention time (Rt), wavelengths of maximum absorption in the visible region (λ~max~), mass spectral data, and identification of phenolic compounds in the six infused blends.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Peak     Rt (min)   λmax\        \[M − H\] *m*/*z*   MS^2^                                                                     Tentative Identification
                      (nm)                                                                                                       
  -------- ---------- ------------ ------------------- ------------------------------------------------------------------------- ----------------------------------------------------------------------------------------
  **1**    4.47       328          311                 179(100),149(83),135(72)                                                  Caftaric acid

  **2**    4.58       324          353                 191(100),179(45),135(7)                                                   3-*O*-Caffeoylquinic acid

  **3**    5.34       319          305                 226(15),175(6),135(40)                                                    Epigallocatechin

  **4**    6.45       319          353                 191(20),179(50),173(100),135(3)                                           4-*O*-Caffeoylquinic acid

  **5**    6.48       267          305                 226(13), 225(100),175(2), 97(44)                                          (+)-Gallocatechin

  **6**    6.81       319          353                 191(100),179(24),173(37)                                                  5-*O*-Caffeoylquinic acid

  **7**    7.88       322          387                 207(100),163(20)                                                          Tuberonic acid glucoside

  **8**    8.8        278          617                 287(100)                                                                  Eriodictyol-7-*O*-rutinoside

  **9**    9.59       320          179                 135(100)                                                                  Caffeic acid

  **10**   9.8        319          313                 197(100)                                                                  Salvianolic acid F

  **11**   10.74      284          449                 287(100)                                                                  Eriodictyol-*O*-hexoside isomer 1

  **12**   11.71      340          337                 191(3),173(100),163(43),155(12),119(12)                                   4-*p*-Coumaroylquinic acid

  **13**   12.2       284          449                 287(100)                                                                  Eriodictyol-*O*-hexoside isomer 2

  **14**   13.33      339          637                 285(100)                                                                  Luteolin-*O*-di-glucuronide

  **15**   14.25      333          473                 311(19),293(19),149(100),135(28)                                          Chicoric acid

  **16**   14.28      343          537                 493(7),339(100),295(90)                                                   Salvianolic acid A isomer 1

  **17**   14.4       310          537                 493(100),359(33),313(5),295(3)                                            Lithospermic acid A

  **18**   14.72      327          555                 537(3),511(3),493(39),311(10),269(20),197(36),179                         Salvianolic acid K

  **19**   15.1       333          521                 359(50),197(20),179(37),161(100)                                          Rosmarinic acid hexoside

  **20**   15.31      334          609                 301(100)                                                                  Quercetin-3-*O*-rutinoside

  **21**   15.58      344          463                 301(100)                                                                  Quercetin-*O*-hexoside

  **22**   15.62      335          491                 311(100),293(20),197(12)                                                  Salvianolic acid C

  **23**   15.96      332          797                 779(100),599(42),555(50),359(37),313(12), 169(5)                          Unknown

  **24**   16.66      351          769                 315(100), 300(10)                                                         Isorhamentin-3-*O*-rhamnosyl-rutinoside

  **25**   17.02      332          421                 153(100)                                                                  4-\[\[(2′,5′Dihydroxybenzoyl)oxy\]methyl\]phenyl-*O*-β-[d]{.smallcaps}-glucopyranoside

  **26**   17.21      272, 324sh   539                 495(13), 359(21), 297(100), 279(64), 197(34), 179(36), 161(34), 135(18)   Yunnaneic acid D isomer

  **27**   17.41      308          609                 301(100)                                                                  Quercetin-*O*-rutinoside

  **28**   17.9       347          477                 301(100)                                                                  Quercetin-*O*-glucuronide

  **29**   18.18      344          717                 519(100),493(8),339(39),321(92),295(23),197(3)                            Salvianolic acid B isomer 1

  **30**   18.45      346          461                 285(100)                                                                  Luteolin-3'-*O*-glucuronide

  **31**   18.81      343          447                 285(100)                                                                  Kaempferol-*O*- hexoside

  **32**   19.86      337          477                 315(100), 300(19)                                                         Isorhamnetin-3-*O*-glucoside

  **33**   19.9       370          549                 505(100),301(74)                                                          Quercetin-7-*O*-malonylhexoside

  **34**   19.97      331          783                 513(100), 497(10), 351(3), 289(55), 245(4)                                Catechin derivative

  **35**   20.24      334          717                 519(100),493(8),339(39),321(92),295(23),197(3)                            Salvianolic acid B isomer 2

  **36**   20.64      343          593                 285(100)                                                                  Kaempferol-3-*O*-rutinoside

  **37**   21.56      330          359                 197(98), 179(94), 161(100), 135(58)                                       *cis*-Rosmarinic acid

  **38**   21.65      344          623                 315(100),300(10)                                                          Isorhamnetin-3-*O*-rutinoside

  **39**   22.43      330          719                 539(12), 521(10), 359(65), 197(6), 179(8), 161(17), 135(3)                Sagerinic acid

  **40**   22.54      328          717                 519(100), 339(27), 321(87), 295(13), 277(33)                              Salvianolic acid L

  **41**   22.68      325          555                 493(50),292(100),197(36),179(29)                                          Salvianolic acid K

  **42**   22.68      330          359                 197(98), 179(94), 161(100), 135(58)                                       *trans*-Rosmarinic acid

  **43**   23.06      337          477                 315(100), 300(19)                                                         Isorhamnetin-3-*O*-glucoside

  **44**   23.69      340          539                 377(100), 307(41),275(31)                                                 Oleuropein

  **45**   23.75      329          549                 505(10), 463(25), 301(100)                                                Quercetin-*O*-malonylhexoside

  **46**   24.63      346          461                 285(100)                                                                  Luteolin-3'-*O*-glucuronide

  **47**   25.45      331          537                 493(100),359(33),313(5),295(3)                                            Lithospermic acid A

  **48**   25.66      344          519                 315(100)                                                                  Isorhamnetin-3-*O*-(6'-acetyl)-glucoside

  **49**   28.43      327          503                 285(100)                                                                  Acetylluteolin-*O*-glucuronide

  **50**   28.89      331          503                 285(100)                                                                  Acetylluteolin-*O*-glucuronide

  **51**   30.39      323          493                 359(84), 313(13), 295(58), 269(7), 197(31), 179(41),161(91),135(86)       Salvianolic acid A isomer 2

  **52**   30.74      331          503                 285 (100)                                                                 Acetylluteolin-*O*-glucuronide
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

References used for identification: \[[@B6-molecules-25-02151]\] for peaks 4 and 47; \[[@B9-molecules-25-02151]\] for peaks 2, 28, 33, 45, and 46; \[[@B28-molecules-25-02151]\] for peak 10; \[[@B21-molecules-25-02151]\] for peaks 5 and 38; \[[@B22-molecules-25-02151]\] for peak 7; \[[@B29-molecules-25-02151]\] for peaks 1, 9, 15, 17, 18, 20, 21, 27, 36, and 41; \[[@B30-molecules-25-02151]\] for peak 3; \[[@B31-molecules-25-02151]\] for peaks 6, 25, and 31; \[[@B32-molecules-25-02151]\] for peak 8; \[[@B33-molecules-25-02151]\] for peaks 11, 13, and 30; \[[@B27-molecules-25-02151]\] for peak 12; \[[@B34-molecules-25-02151]\] for peak 14; \[[@B35-molecules-25-02151]\] for peak 16; \[[@B25-molecules-25-02151]\] for peaks 19, 24, 26, 32, 37, 39, 42, and 48; \[[@B36-molecules-25-02151]\] for peak 22; \[[@B37-molecules-25-02151]\] for peaks 29 and 35; \[[@B38-molecules-25-02151]\] for peak 34; \[[@B39-molecules-25-02151]\] for peaks 40 and 51; \[[@B40-molecules-25-02151]\] for peak 43; \[[@B24-molecules-25-02151]\] for 44; \[[@B41-molecules-25-02151]\] for peaks 49, 50, and 52.

molecules-25-02151-t004_Table 4

###### 

Quantification of the phenolic compounds present in the six infused blends (mean ± SD; mg/g extract).

  Peak     Compounds                                                                                Mix 1                 Mix 2                Mix 3                Mix 4                      Mix 5                 Mix 6
  -------- ---------------------------------------------------------------------------------------- --------------------- -------------------- -------------------- -------------------------- --------------------- --------------------
  **1**    Caftaric acid                                                                            1.60 ± 0.01           nd                   1.8 ± 0.2            nd                         nd                    nd
  **2**    3-*O*-Caffeoylquinic acid                                                                nd                    3.2 ± 0.2 ^a^        nd                   2.15 ± 0.02 ^d^            2.56 ± 0.05 ^c^       2.7 ± 0.1 ^b^
  **3**    Epigallocatechin                                                                         0.066 ± 0.003         nd                   nd                   1.3 ± 0.1                  nd                    nd
  **4**    4-*O*-Caffeoylquinic acid                                                                0.9 ± 0.1 ^c^         1.6 ± 0.1 ^a^        nd                   nd                         nd                    1.2 ± 0.3 ^b^
  **5**    (+)-Gallocatechin                                                                        2.5 ± 0.2             nd                   nd                   nd                         nd                    nd
  **6**    5-*O*-Caffeoylquinic acid                                                                nd                    22.4 ± 0.2 ^a^       nd                   nd                         1.0 ± 0.1 ^c^         1.6 ± 0.2 ^b^
  **7**    Tuberonic acid glucoside                                                                 0.216 ± 0.003         nd                   nd                   nd                         nd                    nd
  **8**    Eriodictyol-7-*O*-rutinoside                                                             nd                    nd                   nd                   nd                         0.69 ± 0.01           nd
  **9**    Caffeic acid                                                                             0.231 ± 0.002         nd                   nd                   nd                         nd                    nd
  **10**   Salvianolic acid F                                                                       nd                    nd                   nd                   1.50 ± 0.01                nd                    nd
  **11**   Eriodictyol-*O*-hexoside isomer 1                                                        nd                    nd                   nd                   nd                         nd                    0.6 ± 0.1
  **12**   4-*p*-Coumaroylquinic acid                                                               0.33 ± 0.04           nd                   nd                   nd                         nd                    nd
  **13**   Eriodictyol-*O*-hexoside isomer 2                                                        nd                    nd                   nd                   nd                         nd                    3.5 ± 0.6
  **14**   Luteolin-*O*-di-glucuronide                                                              nd                    nd                   nd                   nd                         1.891 ± 0.001         nd
  **15**   Chicoric acid                                                                            nd                    nd                   3.5 ± 0.4            nd                         nd                    nd
  **16**   Salvianolic acid A isomer 1                                                              nd                    nd                   nd                   nd                         0.48 ± 0.01           nd
  **17**   Lithospermic acid A                                                                      nd                    nd                   nd                   1.12 ± 0.03                nd                    nd
  **18**   Salvianolic acid K                                                                       0.99 ± 0.01           nd                   nd                   nd                         nd                    nd
  **19**   Rosmarinic acid hexoside                                                                 0.86 ± 0.03           nd                   nd                   nd                         nd                    nd
  **20**   Quercetin-3-*O*-rutinoside                                                               nd                    31 ± 1               nd                   0.20 ± 0.03                nd                    nd
  **21**   Quercetin-*O*-hexoside                                                                   nd                    nd                   nd                   nd                         nd                    8.9 ± 0.1
  **22**   Salvianolic acid C                                                                       0.82 ± 0.03           nd                   nd                   nd                         nd                    nd
  **23**   Unknown                                                                                  nd                    nd                   nd                   nd                         nq                    nd
  **24**   Isorhamentin-3-*O*-rhamnosyl-rutinoside                                                  nd                    nd                   nd                   2.51 ± 0.05                nd                    nd
  **25**   4-\[\[(2′,5′Dihydroxybenzoyl)oxy\]methyl\]phenyl-*O*-β-[d]{.smallcaps}-glucopyranoside   nd                    nd                   nd                   nd                         14.6 ± 0.2            nd
  **26**   Yannaneic acid D isomer                                                                  nd                    nd                   nd                   0.6 ± 0.1                  nd                    nd
  **27**   Quercetin-*O*-rutinoside                                                                 nd                    nd                   0.62 ± 0.01          nd                         nd                    nd
  **28**   Quercetin-*O*-glucuronide                                                                nd                    nd                   1.98 ± 0.05          1.3 ± 0.1                  nd                    nd
  **29**   Salvianolic acid B isomer 1                                                              nd                    nd                   6.3 ± 0.5            nd                         1.26 ± 0.05           nd
  **30**   Luteolin-3'-*O*-glucuronide                                                              4.6 ± 0.1             nd                   nd                   nd                         nd                    nd
  **31**   Kaempferol-*O*- hexoside                                                                 nd                    nd                   nd                   nd                         nd                    35 ± 1
  **32**   Isorhamnetin-3-*O*-glucoside                                                             1.166 ± 0.001         nd                   nd                   nd                         nd                    nd
  **33**   Quercetin-7-*O*-malonylhexoside                                                          nd                    1.4 ± 0.2            nd                   nd                         nd                    nd
  **34**   Catechin derivative                                                                      nd                    nd                   nd                   nd                         nq                    nd
  **35**   Salvianolic acid B isomer 2                                                              nd                    nd                   nd                   0.95 ± 0.05                nd                    nd
  **36**   Kaempferol-3-*O*-rutinoside                                                              nd                    0.6 ± 0.2            nd                   nd                         nd                    nd
  **37**   *cis*-Rosmarinic acid                                                                    nd                    nd                   nd                   13.03 ± 0.05 ^b^           33.9 ± 0.1 ^a^        11.826 ± 0.004 ^c^
  **38**   Isorhamnetin-3-*O*-rutinoside                                                            nd                    2.7 ± 0.1            nd                   nd                         nd                    nd
  **39**   Sagerinic acid                                                                           2.29 ± 0.01 ^b^       nd                   0.93 ± 0.01 ^c^      0.83 ± 0.05 ^d^            4.4 ± 0.1 ^a^         nd
  **40**   Salvianolic acid L                                                                       nd                    nd                   0.9 ± 0.1            nd                         nd                    nd
  **41**   Salvianolic acid K                                                                       nd                    nd                   nd                   nd                         nd                    5 ± 1
  **42**   *trans*-Rosmarinic acid                                                                  0.70 ± 0.01           nd                   nd                   0.9 ± 0.1                  nd                    nd
  **43**   Isorhamnetin-3-*O*-glucoside                                                             nd                    1.08 ± 0.03          nd                   nd                         nd                    nd
  **44**   Oleuropein                                                                               nd                    nd                   9.0 ± 0.3            nd                         nd                    nd
  **45**   Quercetin-*O*-malonylhexoside                                                            0.558 ± 0.005         nd                   nd                   nd                         nd                    nd
  **46**   Luteolin-3'-*O*-glucuronide                                                              1.25 ± 0.03           nd                   nd                   nd                         nd                    nd
  **47**   Lithospermic acid A                                                                      0.6 ± 0.1 ^c^         nd                   nd                   0.67 ± 0.03 ^c^            8.8 ± 0.1 ^a^         1.91 ± 0.01 ^b^
  **48**   Isorhamnetin-3-*O*-(6'-acetyl)-glucoside                                                 nd                    0.90 ± 0.03          nd                   nd                         nd                    nd
  **49**   Acetylluteolin-*O*-glucuronide                                                           0.57 ± 0.02           nd                   nd                   nd                         nd                    nd
  **50**   Acetylluteolin-*O*-glucuronide                                                           0.65 ± 0.04           nd                   nd                   nd                         nd                    nd
  **51**   Salvianolic acid A isomer 2                                                              nd                    nd                   nd                   4.31 ± 0.05                nd                    nd
  **52**   Acetylluteolin-*O*-glucuronide                                                           0.63 ± 0.04           nd                   nd                   nd                         nd                    nd
           **Total Phenolic Acids**                                                                 **9.50 ± 0.03 ^f^**   **27.2 ± 0.1 ^b^**   **22.4 ± 0.1 ^e^**   **26.1053 ± 0.0004 ^c^**   **67.1 ± 0.2 ^a^**    **25 ± 2 ^d^**
           **Total Flavonoids**                                                                     **12.1 ± 0.1 ^c^**    **38 ± 2 ^b^**       **3.5 ± 0.1 ^e^**    **5.29 ± 0.05 ^d^**        **2.58 ± 0.01 ^f^**   **47.1 ± 0.2 ^a^**
           **Total Phenolic Compounds**                                                             **21.6 ± 0.1 ^f^**    **65 ± 2 ^c^**       **23.2 ± 0.2 ^e^**   **31.40 ± 0.05 ^d^**       **69.6 ± 0.2 ^b^**    **72 ± 1 ^a^**

Note: nd: not detected; nq: not quantified. Mix 1: 50% *R. officinalis*, 20% *C. nobile*, 15% *L. nobilis*, 15% *J. regia*. Mix 2: 40% *F. vulgare*, 30% *S. nigra*, 30% *H. perforatum*. Mix 3: 50% *M. pulegium*, 25% *O. europaea*, 25% *V. vinifera*. Mix 4: 60% *M. cervine*, 20% *C. arvensis*, 20% *R. idaeus*. Mix 5: 60% *O. vulgare*, 10% *C. nobile*, 15% *L. nobilis*, 15% *J. regia*. Mix 6: 70% *T. mastichina*, 15% *L. nobilis*, 15% *J. regia.* Calibration curves: chlorogenic acid (*y* = 168,823*x* -- 161,172; *R*^2^ = 1.000; LOD = 0.20 µg/mL; LOQ = 0.68 µg/mL; peaks 1, 2, 4, 6, and 15); epicatechin (*y* = 10,314*x* + 147,331; *R*^2^ = 0.9998; LOD = 0.15 μg/mL; LOQ = 0.78 μg/mL; peaks 3 and 5); *p*-coumaric acid (*y* = 301,950*x* + 6966.7; *R*^2^ = 0.9999; LOD = 0.68 μg/mL; LOQ = 1.61 μg/mL; peaks 7 and 12); naringenin (*y* = 18,433x + 78,903; *R*^2^ = 0.9997; LOD = 0.17 µg/mL; LOQ = 0.81 µg/mL; peaks 8 and 13); caffeic acid (*y* = 388,345*x* + 406,369; *R*^2^ = 0.9991; LOD = 0.78 μg/mL; LOQ = 1.97 μg/mL; peaks 9 and 12); rosmarinic acid (*y* = 191,291*x* -- 652,903; *R*^2^ = 0.999; LOD = 0.15 µg/mL; LOQ = 0.68 µg/mL; peaks 10, 16, 17, 18, 19, 22, 26, 29, 35, 37, 39, 40, 41, 42, 47, and 51); quercetin-3-*O*-glucoside (*y* = 34,843x -- 160,173; *R*^2^ = 1.000; LOD 0.21 μg/mL; LOQ 0.71 μg/mL; peaks 14, 21, 28, 32, 33, 43, 45, 46, 48, 49, 50, and 52); quercetin-3-*O*-rutinoside (*y* = 13,343*x* + 76,751; *R*^2^ = 0.9998; LOD 0.18 μg/mL; LOQ 0.65 μg/mL; peaks 20, 24, 27, 30, 31, 36, and 38); protocatechuic acid (*y* = 214,168*x* + 27,102; *R*^2^ = 0.9997; LOD = 0.14 μg/mL; LOQ = 0.52 μg/mL; peak 25); oleuropein (*y* = 32,226*x* + 12,416; *R*^2^ = 0.9997; LOD = 0.69µg/mL and LOQ = 1.96 µg/mL; peak 44). The statistical treatment was performed by comparing the mixes; therefore, in each row different letters indicate statistically significant differences (*p* \< 0.05). Mean statistical differences obtained by Student's *t*-test for peaks 1, 3, 20, 28, 29, and 42 was \<0.001.

molecules-25-02151-t005_Table 5

###### 

Antioxidant, anti-inflammatory, and cytotoxic activity of the six infused blends (mean ± SD).

                                                   Mix 1           Mix 2            Mix 3           Mix 4        Mix 5           Mix 6
  ------------------------------------------------ --------------- ---------------- --------------- ------------ --------------- ---------------
  **Antioxidant activity (IC~50~, µg/mL)**                                                                                       
  TBARS                                            4.5 ± 0.2 ^f^   23.1 ± 0.3 ^a^   14 ± 1 ^c^      22 ± 1 ^b^   9 ± 1 ^d^       6.9 ± 0.3 ^e^
  OxHLIA (Δt = 60 min)                             22 ± 1 ^c^      106 ± 4 ^a^      9.7 ± 0.7 ^e^   12 ± 2 ^d^   4.0 ± 0.6 ^f^   35 ± 2 ^b^
  **Cytotoxic activity (GI~50~, µg/mL)**                                                                                         
  MCF-7                                            209 ± 5 ^c^     \>400            238 ± 4 ^b^     \>400        236 ± 16 ^b^    254 ± 17 ^a^
  NCI-H460                                         257 ± 10 ^b^    \>400            320 ± 12 ^a^    \>400        250 ± 13 ^b^    258 ± 16 ^b^
  HeLa                                             246 ± 16 ^a^    \>400            217 ± 11 ^c^    \>400        213 ± 9 ^c^     227 ± 10 ^b^
  HepG2                                            226 ± 13 ^b^    \>400            304 ± 6 ^a^     \>400        230 ± 25 ^b^    175 ± 18 ^c^
  PLP2                                             \>400           \>400            \>400           \>400        \>400           \>400
  **Anti-inflammatory activity (IC~50~, µg/mL)**                                                                                 
  RAW 246.7                                        321 ± 4 ^a^     \>400            276 ± 12^b^     \>400        276 ± 12 ^b^    262 ± 17 ^c^

Mix 1: 50% R. officinalis, 20% C. nobile, 15% L. nobilis, 15% J. regia. Mix 2: 40% F. vulgare, 30% S. nigra, 30% H. perforatum. Mix 3: 50% M. pulegium, 25% O. europaea, 25% V. vinifera. Mix 4: 60% M. cervine, 20% C. arvensis, 20% R. idaeus. Mix 5: 60% O. vulgare, 10% C. nobile, 15% L. nobilis, 15% J. regia. Mix 6: 70% T. mastichina, 15% L. nobilis, 15% J. regia. EC~50~ values corresponded to the extract concentration that inhibits 50% of the oxidation and inflammatory processes. Trolox (IC~50~ values): TBARS (thiobarbituric acid reactive species): 5.8 ± 0.6 µg/mL; OxHLIA (oxidative hemolysis inhibition, 60 min): 85 ± 2 µg/mL. Dexamethasone (IC~50~ values): 16 ± 1 µg/mL. GI~50~ values correspond to the concentration that causes 50% inhibition of cell proliferation. Note: MCF-7 = human breast adenocarcinoma; NCI-H460 = human lung carcinoma; HeLa = human cervix adenocarcinoma; HepG2 = hepatocellular carcinoma; PLP2 = primary culture of non-tumoral pig liver cells. Ellipticine (GI~50~ values): MCF-7: 1.21 ± 0.02 µg/mL; NCI-H460: 0.91 ± 0.11 µg/mL; HeLa: 1.03 ± 0.09 µg/mL; HepG2: 1.1 ± 0.09 µg/mL; PLP2: 2.29 ± 0.18 µg/mL. Raw 246.7 (Mouse lipopolysaccharide (LPS)-stimulated macrophage-like cell line). Results expressed as mean values ± standard deviation (SD). The statistical treatment was performed by comparing the mixtures; therefore, in each row different letters indicate statistically significant differences (*p* \< 0.05).

molecules-25-02151-t006_Table 6

###### 

Antimicrobial activity of the six infused blends and positive controls.

                                       Mix 1   Mix 2   Mix 3   Mix 4   Mix 5   Mix 6   E221   E224                                                 
  ------------------------------------ ------- ------- ------- ------- ------- ------- ------ ------ ------ ------ ------ ------ ----- ----- ----- -----
  **Antibacterial activity (mg/mL)**                                                                                                               
  **Bacteria**                         MIC     MBC     MIC     MBC     MIC     MBC     MIC    MBC    MIC    MBC    MIC    MBC    MIC   MBC   MIC   MBC
  ***Gram-negative***                                                                                                                              
  *Salmonella* Typhymurium             0.5     1       4       8       1       2       2      2      1      2      1      1      1     2     1     1
  *Enterobacter cloacae*               0.5     1       2       2       1       2       1      2      1      2      1      2      2     4     0.5   0.5
  ***Gram-positive***                                                                                                                              
  *Bacillus cereus*                    1       1       1       2       1       2       1      2      1      2      1      1      0.5   0.5   2     4
  *Listeria monocytogenes*             0.5     1       2       2       1       2       1      2      1      2      1      2      1     2     0.5   1
  *Staphylococcus aureus*              0.25    0.25    1       1       0.25    0.5     0.25   0.25   0.25   0.5    0.25   0.5    4     4     1     1
  *Micrococcus flavus*                 2       2       2       4       2       4       1      2      1      2      1      2      1     2     1     2
  **Antifungal activity (mg/mL)**                                                                                                                  
  **Fungi**                            MIC     MFC     MIC     MFC     MIC     MFC     MIC    MFC    MIC    MFC    MIC    MFC    MIC   MFC   MIC   MFC
  *Aspergillus niger*                  0.5     1       0.5     1       1       1       0.5    1      0.5    1      0.25   0.5    1     2     1     1
  *Aspergillus versicolor*             0.5     1       0.5     1       1       1       0.5    0.5    0.5    1      0.25   0.5    2     2     1     1
  *Aspergillus fumigatus*              0.5     1       0.5     1       1       1       0.5    1      1      2      0.25   5      1     2     1     1
  *Penicillium funiculosum*            0.25    0.5     0.5     0.5     0.25    0.5     0.12   0.25   0.12   0.25   0.12   0.25   1     2     0.5   0.5
  *Penicillium aurantiogriseum*        0.5     1       1       2       0.5     1       1      2      0.5    1      0.5    1      2     4     1     1

Note: MIC = minimal inhibitory concentration; MBC = minimal bactericidal concentration; MFC = minimal fungal concentration. Mix 1: 50% *R. officinalis*, 20% *C. nobile*, 15% *L. nobilis*, 15% *J. regia*. Mix 2: 40% *F. vulgare*, 30% *S. nigra*, 30% *H. perforatum*. Mix 3: 50% *M. pulegium*, 25% *O. europaea*, 25% *V. vinifera*. Mix 4: 60% *M. cervine*, 20% *C. arvensis*, 20% *R. idaeus*. Mix 5: 60% *O. vulgare*, 10% *C. nobile*, 15% *L. nobilis*, 15% *J. regia*. Mix 6: 70% *T. mastichina*, 15% *L. nobilis*, 15% *J. regia.*
